Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Environmental and Drug Effects on Patients With Pacemakers and Implantable Cardioverter/Defibrillators

Environmental and Drug Effects on Patients With Pacemakers and Implantable... SPECIAL ARTICLE Environmental and Drug Effects on Patients With Pacemakers and Implantable Cardioverter/Defibrillators A Practical Guide to Patient Treatment Nora Goldschlager, MD; Andrew Epstein, MD; Paul Friedman, MD; Eli Gang, MD; Ryszard Krol, MD, PhD; Brian Olshansky, MD; for the North American Society of Pacing and Electrophysiology (NASPE) Practice Guideline Committee he potential for interaction between pacemakers and implantable cardioverter/ defibrillators (ICDs) and the medical and nonmedical environment, and between these devices and certain cardioactive drugs, has been recognized for years. Whereas a num- T ber of experimental and clinical studies have been performed to define some of these interactions, in many instances data are sparse and anecdotal clinical experiences form the basis for decision making and recommendations. Nevertheless, given the proliferation of rhythm- management devices in use in the population today, practitioners may find a guide to manage- ment of these patients helpful. This management guideline is therefore offered not as an extensive, literature-based review, but as a framework on which to understand specific types of problems that may be encountered in the daily lives of patients who have such implanted devices. ELECTROMAGNETIC of cellular telephones. Although no re- INTERFERENCE IN PATIENTS cent studies that systematically test the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Environmental and Drug Effects on Patients With Pacemakers and Implantable Cardioverter/Defibrillators

Loading next page...
 
/lp/american-medical-association/environmental-and-drug-effects-on-patients-with-pacemakers-and-Vh5FzeaUXP

References (21)

Publisher
American Medical Association
Copyright
Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinte.161.5.649
Publisher site
See Article on Publisher Site

Abstract

SPECIAL ARTICLE Environmental and Drug Effects on Patients With Pacemakers and Implantable Cardioverter/Defibrillators A Practical Guide to Patient Treatment Nora Goldschlager, MD; Andrew Epstein, MD; Paul Friedman, MD; Eli Gang, MD; Ryszard Krol, MD, PhD; Brian Olshansky, MD; for the North American Society of Pacing and Electrophysiology (NASPE) Practice Guideline Committee he potential for interaction between pacemakers and implantable cardioverter/ defibrillators (ICDs) and the medical and nonmedical environment, and between these devices and certain cardioactive drugs, has been recognized for years. Whereas a num- T ber of experimental and clinical studies have been performed to define some of these interactions, in many instances data are sparse and anecdotal clinical experiences form the basis for decision making and recommendations. Nevertheless, given the proliferation of rhythm- management devices in use in the population today, practitioners may find a guide to manage- ment of these patients helpful. This management guideline is therefore offered not as an extensive, literature-based review, but as a framework on which to understand specific types of problems that may be encountered in the daily lives of patients who have such implanted devices. ELECTROMAGNETIC of cellular telephones. Although no re- INTERFERENCE IN PATIENTS cent studies that systematically test the

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Mar 12, 2001

There are no references for this article.